Total Payments
$39,909
2024 Payments
$5,657
Companies
9
Transactions
98
Payment Breakdown by Category
Other$19,875 (49.8%)
Consulting$11,808 (29.6%)
Travel$5,533 (13.9%)
Food & Beverage$2,332 (5.8%)
Education$361.69 (0.9%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Honoraria | $19,875 | 12 | 49.8% |
| Consulting Fee | $11,808 | 4 | 29.6% |
| Travel and Lodging | $5,533 | 19 | 13.9% |
| Food and Beverage | $2,332 | 51 | 5.8% |
| Education | $361.69 | 12 | 0.9% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Rhythm Pharmaceuticals, Inc. | $24,113 | 42 | $0 (2024) |
| Novo Nordisk Inc | $9,984 | 40 | $0 (2024) |
| VIVUS LLC | $5,278 | 8 | $0 (2024) |
| Alexion Pharmaceuticals, Inc. | $186.07 | 2 | $0 (2019) |
| AstraZeneca Pharmaceuticals LP | $120.44 | 1 | $0 (2019) |
| PFIZER INC. | $100.00 | 1 | $0 (2017) |
| Itamar Medical Inc | $94.97 | 1 | $0 (2024) |
| Retrophin, Inc. | $19.50 | 2 | $0 (2019) |
| Ferring Pharmaceuticals Inc. | $12.10 | 1 | $0 (2017) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $5,657 | 18 | VIVUS LLC ($5,090) |
| 2023 | $8,467 | 27 | Rhythm Pharmaceuticals, Inc. ($7,783) |
| 2022 | $15,954 | 38 | Rhythm Pharmaceuticals, Inc. ($15,504) |
| 2021 | $781.50 | 2 | Rhythm Pharmaceuticals, Inc. ($781.50) |
| 2020 | $3,535 | 2 | Novo Nordisk Inc ($3,535) |
| 2019 | $5,333 | 8 | Novo Nordisk Inc ($5,077) |
| 2017 | $181.32 | 3 | PFIZER INC. ($100.00) |
All Payment Transactions
98 individual payment records from CMS Open Payments — Page 1 of 4
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 09/16/2024 | Novo Nordisk Inc | Saxenda (Drug) | Education | In-kind items and services | $32.27 | General |
| Category: Obesity | ||||||
| 09/16/2024 | Novo Nordisk Inc | Saxenda (Drug) | Education | In-kind items and services | $32.27 | General |
| Category: Obesity | ||||||
| 09/16/2024 | Novo Nordisk Inc | Saxenda (Drug) | Education | In-kind items and services | $32.27 | General |
| Category: Obesity | ||||||
| 09/16/2024 | Novo Nordisk Inc | Saxenda (Drug) | Education | In-kind items and services | $32.27 | General |
| Category: Obesity | ||||||
| 09/16/2024 | Novo Nordisk Inc | Saxenda (Drug) | Education | In-kind items and services | $32.27 | General |
| Category: Obesity | ||||||
| 09/16/2024 | Novo Nordisk Inc | Saxenda (Drug) | Education | In-kind items and services | $32.27 | General |
| Category: Obesity | ||||||
| 09/16/2024 | Novo Nordisk Inc | Saxenda (Drug) | Education | In-kind items and services | $32.27 | General |
| Category: Obesity | ||||||
| 09/12/2024 | VIVUS LLC | QSYMIA (Drug) | Consulting Fee | Cash or cash equivalent | $1,250.00 | General |
| Category: ENDOCRINOLOGY | ||||||
| 05/09/2024 | VIVUS LLC | QSYMIA (Drug) | Consulting Fee | Cash or cash equivalent | $3,750.00 | General |
| Category: ENDOCRINOLOGY | ||||||
| 05/08/2024 | Novo Nordisk Inc | Wegovy (Drug) | Food and Beverage | In-kind items and services | $18.57 | General |
| Category: Obesity | ||||||
| 05/07/2024 | Rhythm Pharmaceuticals, Inc. | IMCIVREE (Drug) | Food and Beverage | In-kind items and services | $20.27 | General |
| Category: Genetic Disease | ||||||
| 04/27/2024 | VIVUS LLC | QSYMIA (Drug) | Food and Beverage | In-kind items and services | $89.76 | General |
| Category: ENDOCRINOLOGY | ||||||
| 04/25/2024 | Novo Nordisk Inc | — | Food and Beverage | In-kind items and services | $62.45 | General |
| 03/20/2024 | Rhythm Pharmaceuticals, Inc. | IMCIVREE (Drug) | Food and Beverage | In-kind items and services | $25.44 | General |
| Category: Genetic Disease | ||||||
| 02/28/2024 | Novo Nordisk Inc | — | Food and Beverage | In-kind items and services | $104.97 | General |
| 02/15/2024 | Novo Nordisk Inc | Wegovy (Drug) | Food and Beverage | In-kind items and services | $14.42 | General |
| Category: Obesity | ||||||
| 02/15/2024 | Novo Nordisk Inc | Wegovy (Drug) | Food and Beverage | In-kind items and services | $0.09 | General |
| Category: Obesity | ||||||
| 01/24/2024 | Itamar Medical Inc | WatchPATONE (Device) | Food and Beverage | Cash or cash equivalent | $94.97 | General |
| Category: Sleep Apnea testing | ||||||
| 12/14/2023 | VIVUS LLC | QSYMIA (Drug) | Food and Beverage | In-kind items and services | $22.20 | General |
| Category: ENDOCRINOLOGY | ||||||
| 12/14/2023 | Novo Nordisk Inc | Wegovy (Drug) | Food and Beverage | In-kind items and services | $6.16 | General |
| Category: Obesity | ||||||
| 11/15/2023 | Rhythm Pharmaceuticals, Inc. | Imcivree (Drug) | Food and Beverage | In-kind items and services | $13.29 | General |
| Category: Genetic Disease | ||||||
| 11/09/2023 | VIVUS LLC | QSYMIA (Drug) | Food and Beverage | In-kind items and services | $13.46 | General |
| Category: ENDOCRINOLOGY | ||||||
| 09/27/2023 | Novo Nordisk Inc | — | Food and Beverage | In-kind items and services | $91.96 | General |
| 09/22/2023 | Rhythm Pharmaceuticals, Inc. | Imcivree (Drug) | Honoraria | Cash or cash equivalent | $3,000.00 | General |
| Category: Genetic Disease | ||||||
| 09/22/2023 | Rhythm Pharmaceuticals, Inc. | Imcivree (Drug) | Travel and Lodging | In-kind items and services | $596.44 | General |
| Category: Genetic Disease | ||||||
About Dr. Suzanne Cuda, MD
Dr. Suzanne Cuda, MD is a Adolescent Medicine healthcare provider based in San Antonio, Texas. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 11/03/2005. The National Provider Identifier (NPI) number assigned to this provider is 1841281235.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Suzanne Cuda, MD has received a total of $39,909 in payments from pharmaceutical and medical device companies, with $5,657 received in 2024. These payments were reported across 98 transactions from 9 companies. The most common payment nature is "Honoraria" ($19,875).
Ad
Practice Information
- Specialty Adolescent Medicine
- Other Specialties Obesity Medicine
- Location San Antonio, TX
- Active Since 11/03/2005
- Last Updated 11/15/2024
- Taxonomy Code 2080A0000X
- Entity Type Individual
- NPI Number 1841281235
Products in Payments
- Imcivree (Drug) $16,192
- QSYMIA (Drug) $5,278
- Saxenda (Drug) $356.46
- Wegovy (Drug) $317.52
- FASENRA (Drug) $120.44
- EUCRISA (Drug) $100.00
- WatchPATONE (Device) $94.97
- Strensiq (Drug) $69.22
- Victoza (Drug) $64.54
- IMCIVREE (Drug) $45.71
- (820) Cholbam (Drug) $19.50
- ZOMACTON (Drug) $12.10
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Adolescent Medicine Doctors in San Antonio
Miss. Danielle Stramandi, M.d, M.D
Adolescent Medicine — Payments: $4,268
Adolescent Medicine $4,268
Dr. Gabriel Perez, Md, MD
Adolescent Medicine — Payments: $1,435
Adolescent Medicine $1,435
Nidhi Kudur, Do, DO
Adolescent Medicine — Payments: $786.70
Adolescent Medicine $786.70
Dr. Scott Leggoe, D.o, D.O
Adolescent Medicine — Payments: $26.03
Adolescent Medicine $26.03
Dr. Vivian Carlin, M.d, M.D
Adolescent Medicine — Payments: $19.46
Adolescent Medicine $19.46
Dr. Janna Wilder, M.d, M.D
Adolescent Medicine
Adolescent Medicine